MecobalActive Provides Sustainable Solution for Vitamin B12 Supplements to Reduce Pollution Impact on Earth
December 09, 2019 11:58 ET
|
MecobalActive
ANN ARBOR, Mich., Dec. 09, 2019 (GLOBE NEWSWIRE) -- Vitamin B12 may help protect the body against the damaging effects of air pollution, but the production process for certain forms of vitamin B12...
Elev8 MD Wellness Center to Host Special Reception Featuring Oprah Winfrey Network Actors Timon Kyle Durrett of “Queen Sugar” and William Bryant, Jr. of “Greenleaf”
November 07, 2019 16:45 ET
|
Elev8 Wellness Center
CHARLOTTE, N.C., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Elev8 MD Wellness Center is pleased to announce two actors from the Oprah Winfrey Television Network (OWN) will host a special reception at the...
b-2Cool’s U.S. Strategy Extinguishes Fires to Reshape Native Type II Collagen Market
June 27, 2019 16:08 ET
|
b-2Cool
ANN ARBOR, Mich., June 27, 2019 (GLOBE NEWSWIRE) -- Bioiberica’s entry into the U.S. market for its native (undenatured) type II collagen, b-2Cool, through exclusive distributer Berg Nutrition, was...
Sucampo Pharmaceuticals Announces its Participation at the Global Mizuho Investor Conference
November 27, 2017 16:10 ET
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Nov. 27, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will participate in investor...
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 29th Annual Piper Jaffray Healthcare Conference
November 21, 2017 16:10 ET
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will participate in a fireside...
Sucampo Reports Third Quarter 2017 Financial Results
November 01, 2017 06:30 ET
|
Sucampo Pharmaceuticals Inc
Company Increases 2017 Financial Guidance Based on Strong Performance Year to Date Study Results for VTS-270 for Niemann-Pick Disease Type C1 Published in The Lancet CPP-1X/sulindac Granted...
Sucampo Announces Third Quarter 2017 Earnings Call
October 23, 2017 16:05 ET
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Oct. 23, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that it will host its third quarter 2017...
Sucampo Pharmaceuticals Announces Issuance of New Patent for VTS-270
June 13, 2017 16:30 ET
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., June 13, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that the U.S. Patent and Trademark Office...
Sucampo Reports First Quarter 2017 Financial Results
May 03, 2017 06:30 ET
|
Sucampo Pharmaceuticals Inc
Continued Revenue Growth Recent Vtesse Acquisition Bolsters Pipeline Company Reiterates 2017 Guidance Company to Host Conference Call Today at 8:30 a.m. EDT ROCKVILLE, Md., May 03, 2017 (GLOBE...
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Deutsche Bank 42nd Annual Health Care Conference
April 26, 2017 16:01 ET
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., April 26, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...